Sunway Healthcare Holdings Bhd (XKLS:5555) Debt-to-EBITDA : 2.41 (As of Jun. 2026) — 31% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:5555 Sunway Healthcare Holdings Bhd XKLS:5555
9 GF Score
Price RM2.11
! 1 Warning Sign
View Full Analysis

What is Sunway Healthcare Holdings Bhd Debt-to-EBITDA?

Sunway Healthcare Holdings Bhd XKLS:5555 +0.48% 9 Debt-to-EBITDA is 2.41 as of Jun. 2026, which is 31% above its 10-year median of 1.84. GuruFocus rates XKLS:5555 with a GF Score™ of 9/100. The stock has 1 warning sign investors should review. Among 480 Healthcare Providers & Services companies, Sunway Healthcare Holdings Bhd ranks worse than 70.21% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sunway Healthcare Holdings Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was RM523 Mil. Sunway Healthcare Holdings Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was RM1,105 Mil. Sunway Healthcare Holdings Bhd's annualized EBITDA for the quarter that ended in Jun. 2026 was RM676 Mil. Sunway Healthcare Holdings Bhd's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 2.41.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sunway Healthcare Holdings Bhd's Debt-to-EBITDA or its related term are showing as below:

XKLS:5555' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.13   Med: 1.84   Max: 3.79
Current: 3.79

During the past 3 years, the highest Debt-to-EBITDA Ratio of Sunway Healthcare Holdings Bhd was 3.79. The lowest was 0.13. And the median was 1.84.

XKLS:5555's Debt-to-EBITDA is ranked worse than
70.21% of 480 companies
in the Healthcare Providers & Services industry
Industry Median: 2.185 vs XKLS:5555: 3.79

Sunway Healthcare Holdings Bhd  (XKLS:5555) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sunway Healthcare Holdings Bhd Debt-to-EBITDA Related Terms


Sunway Healthcare Holdings Bhd Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Sunway Healthcare Holdings Bhd's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunway Healthcare Holdings Bhd Debt-to-EBITDA Chart

Sunway Healthcare Holdings Bhd Annual Data
Trend Dec22 Dec23 Dec24
Debt-to-EBITDA
0.13 1.84 2.23

Sunway Healthcare Holdings Bhd Quarterly Data
Dec22 Dec23 Dec24 Mar25 Jun25 Sep25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial 0.00 0.00 2.31 3.48 2.41

XKLS:5555 vs HCA, THC, DVA: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Sunway Healthcare Holdings Bhd's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunway Healthcare Holdings Bhd Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sunway Healthcare Holdings Bhd's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sunway Healthcare Holdings Bhd's Debt-to-EBITDA falls into.


XKLS:5555
9GF Score
Sunway Healthcare Holdings Bhd XKLS:5555
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunway Healthcare Holdings Bhd Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sunway Healthcare Holdings Bhd's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(289.042 + 794.474) / 485.599
=2.23

Sunway Healthcare Holdings Bhd's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(523.208 + 1104.833) / 675.824
=2.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of 2.41 mean?
Sunway Healthcare Holdings Bhd (XKLS:5555) has a Debt-to-EBITDA of 2.41 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Sunway Healthcare Holdings Bhd. This is 31% above median its historical median of 1.84. Over the past decade, Sunway Healthcare Holdings Bhd's Debt-to-EBITDA has ranged from 0.13 to 3.79. According to the industry distribution chart, Sunway Healthcare Holdings Bhd ranks #337 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 70.2%.
Is Sunway Healthcare Holdings Bhd's Debt-to-EBITDA too high?
Sunway Healthcare Holdings Bhd's current Debt-to-EBITDA of 2.41 is 31% above median its 10-year median of 1.84. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 3.79. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Sunway Healthcare Holdings Bhd's value of 2.41 is 10.3% above this industry median. Based on the distribution chart, Sunway Healthcare Holdings Bhd ranks #337 out of 480 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sunway Healthcare Holdings Bhd has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Sunway Healthcare Holdings Bhd's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sunway Healthcare Holdings Bhd ranks #337 out of 480 companies for Debt-to-EBITDA. This places Sunway Healthcare Holdings Bhd in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Sunway Healthcare Holdings Bhd's value of 2.41 is 10.3% above this benchmark. Historically, Sunway Healthcare Holdings Bhd's own Debt-to-EBITDA has ranged from 0.13 to 3.79 over the past decade. While the company's 10-year median is 1.84 vs. the industry median of 2.19, Sunway Healthcare Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunway Healthcare Holdings Bhd's current Debt-to-EBITDA of 2.41 is 10.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Sunway Healthcare Holdings Bhd. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunway Healthcare Holdings Bhd's current Debt-to-EBITDA is 2.41, which is 31% above median its own 10-year median of 1.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunway Healthcare Holdings Bhd stock overvalued right now?
Sunway Healthcare Holdings Bhd (XKLS:5555) has a current Debt-to-EBITDA of 2.41. The current Debt-to-EBITDA is 2.41, which is 31% above median its 10-year median of 1.84 and 10.3% above the Healthcare Providers & Services industry median of 2.19. Sunway Healthcare Holdings Bhd's overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Sunway Healthcare Holdings Bhd (XKLS:5555), the current Debt-to-EBITDA is 2.41 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunway Healthcare Holdings Bhd Business Description

Address No. 5, Jalan Lagoon Selatan, Level 6, Tower A, Sunway Medical Centre Sunway City, Bandar Sunway, Subang Jaya, SGR, MYS, 47500
Sunway Healthcare Holdings Bhd is an investment holding company. Through its subsidiaries, it is principally involved in the (i) operation of medical centres; (ii) provision of a wide range of facilities and services for persons in need of senior living care and assistance; (iii) provision of ambulatory care services; and (iv) operation of TCM centres. The company operates two segments: Hospital services, which include medical centre operations and consultation services, and Others, which include investment holding, financial services, senior living care, TCM centres, nursing and ambulatory care, training, property leasing, and related activities. The majority of revenue is generated from the Hospital services segment. Geographically, the maximum revenue is generated from Malaysia.
9GF Score

Get the complete analysis for XKLS:5555

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM2.11
Price